Study reveals benign brain tumours can cause more emotional harm than malignant tumours
(Medical Xpress)—In a paper published in the Journal of Neuro-oncology, researchers have found that that patients with benign brain tumours experience greater distress than those with malignant tumours before radiation therapy
"Most would assume that a benign tumour would cause less distress in patients but these results show at early diagnosis this is the opposite. Participants with benign tumours showed substantially elevated distress relative to patients with a malignant tumour," says lead researcher Dr Maria Kangas.
Researchers studied groups of patients diagnosed with a range of brain tumours and assessed their mood, stress and overall quality of life to measure the effects of radiotherapy on the psychosocial cognitive functioning in adults.
Though patients with a benign brain tumour did report a decline in stress following radiation therapy (as did malignant brain tumour patients) these results are important to understand the range of emotional needs of patients with brain tumours.
"Quite often people feel that having a benign tumour is not as much of a problem but this isn't the case. Both benign and malignant tumors can be life-threatening and can cause brain function impairments as well as psychosocial problems," says Dr Kangas.
Another interesting finding from the research was the difference in stress levels between patients with tumours in the left hemisphere of the brain compared to right hemisphere brain tumours.
"We found that patients with left hemisphere tumours were more susceptible to experiencing elevated stress and mood disturbances. This makes a lot of sense, as left hemisphere effects how we respond emotionally,' says Dr Kangas.
"These findings highlight the importance of screening for psychosocial and cognitive disturbances for patients with brain tumours undergoing treatment. It's crucial to identify patients who may be at risk of experiencing acute and more prolonged problems," say Dr Kangas.
According to the Brain Foundation, there are almost 1,400 new cases of malignant brain tumours in Australia with more than 1,200 people dying each year from malignant and benign brain tumours. The prevalence rates for clinical depression and anxiety have been found to be as high as 62.5% in adults treated for brain tumours.
The Macquarie University Cancer Institute has just launched a new brain tumour clinic and say this research is vital to the improving treatment for patients with brain tumours.
"It is vital to integrate psychological research into our programs and this is an important study," said Dr Andrew Davidson, lead clinician for neuro-oncology at Macquarie Cancer Institute.
"It's really scary when someone develops a brain tumour. It is not enough for a patient to have an operation; we need to look after them as a whole person and help them to deal with the difficult issues they face both emotional and physical," says Professor John Boyages, Director of the Macquarie University Cancer Institute (MCI).
"This is the advantage we have at the Macquarie University Hospital with a team of health professionals that includes a psychologist and expert nurses.
Journal reference:
Journal of Neuro-oncology
Provided by
Macquarie University
-
Children's brain tumors more diverse than previously believed
May 14, 2012 |
not rated yet |
0
-
Genetic markers hope for new brain tumor treatments
Jun 15, 2012 |
not rated yet |
0
-
A better diagnostic tool for brain cancer
Jun 07, 2012 |
not rated yet |
0
-
Some breast cancer tumors may be resistant to a common chemotherapy treatment
Mar 27, 2012 |
not rated yet |
0
-
'Fingerprinting' breakthrough offers improved brain tumour diagnosis
Sep 21, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
4 hours ago
-
If you became brain-dead, would you want them to pull the plug?
21 hours ago
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
ASCO: combo antibody therapy effective for melanoma
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer
16 hours ago |
not rated yet |
0
Risk factors ID'd for poor cutaneous cell CA outcomes
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer
17 hours ago |
not rated yet |
0
|
Physical & emotional impairments common, often untreated in people with cancer
A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D., associate professor at Harvar ...
Cancer
21 hours ago |
not rated yet |
0
Calif. doc with 'cancer cure' gets 14 years prison (Update)
(AP)—A California doctor has been sentenced to 14 years in federal prison for bilking her patients out of more than $1 million by promising that an herbal supplement could cure late-stage cancer and other diseases.
Cancer
22 hours ago |
not rated yet |
0
New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Individuals who drink heavily and smoke may show 'early aging' of the brain
Treatment for alcohol use disorders works best if the patient actively understands and incorporates the interventions provided in the clinic. Multiple factors can influence both the type and degree of neurocognitive abnormalities ...